Flanvotumab
Flanvotumab
Flanvotumab (pronounced as flan-vo-toom-ab) is a novel monoclonal antibody designed for the treatment of various types of cancer.
Etymology
The term "Flanvotumab" is derived from the Latin words 'flanvo' meaning 'yellow' and 'tumab' meaning 'swelling', referring to its use in treating cancerous tumors.
Usage
Flanvotumab is used in the field of oncology to target and destroy cancer cells. It is a type of immunotherapy, which uses the body's immune system to fight cancer.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Oncology: The branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
- Immunotherapy: A type of cancer treatment that helps your immune system fight cancer.
See Also
External links
- Medical encyclopedia article on Flanvotumab
- Wikipedia's article - Flanvotumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski